Sideroflexin 3 is a Mitochondrial Protein Enriched in Neurons

AbstractSideroflexin 1 (Sfxn1) is a mitochondrial serine transporter involved in one-carbon metabolism in blood and cancer cell lines. The expression of other Sfxn homologs varies across tissues implying that each homolog may have tissue-specific functions. RNA databases suggest that among the Sfxns, Sfxn3 may have a specific function in the brain. Here, we systematically analyzed the level, cellular distribution, and subcellular localization of Sfxn3 protein in the developing and adult rodent brain. We found that, in the cortex and hippocampus, Sfxn3 protein level is low at birth but increases during development and remains at a high level in the mature brains. Similarly, in cultured hippocampal neurons, Sfxn3 protein level is low in young neurons but increases as neurons mature. Sfxn3 protein level is much higher in neurons than in astrocytes. Within neurons, Sfxn3 localizes to mitochondria in all major neuronal compartments. Our results establish that Sfxn3 is a mitochondrial protein enriched in neurons wherein it is developmentally expressed. These findings provide a foundation for future research aimed at understanding the functions of Sfxn3 and one-carbon metabolism in neurons.
Source: NeuroMolecular Medicine - Category: Neurology Source Type: research

Related Links:

Publication date: Available online 2 April 2020Source: Brain, Behavior, and ImmunityAuthor(s): Julienne E. Bower, Kate R. Kuhlman, Patricia A. Ganz, Michael R. Irwin, Catherine M. Crespi, Steve W. Cole
Source: Brain, Behavior, and Immunity - Category: Neurology Source Type: research
Authors: Sartore-Bianchi A, Pizzutilo EG, Marrapese G, Tosi F, Cerea G, Siena S Abstract Introduction: Gene fusions are strong driver alterations in various cancers, increasingly diagnosed with multiple testing techniques. ROS1 fusions can be found in 1-2% of non-small cell lung cancer (NSCLC) and several tyrosine kinase inhibitors (TKIs) have been tested in this oncogene-driven disease. NTRK fusions are characteristic of a few rare types of cancer, also infrequently seen in some common cancers including NSCLC. Entrectinib is a newer ROS1 and NTRK inhibitor developed across different tumour types harbouring rearran...
Source: Expert Review of Anticancer Therapy - Category: Cancer & Oncology Tags: Expert Rev Anticancer Ther Source Type: research
This week, reassessing the age of the ‘Broken Hill skull’, and unearthing evidence of an ancient forest near the South Pole.In this episode:01:25 A skull’s place in historyAfter nearly a century scientists believe they’ve finally pinned down an age for the ‘Broken Hill skull’ hominid specimen. Research Article: Grun et al.07:44 Research HighlightsA simple way to detect early signs of cancer, and 3D printed soft brain implants. Research Highlight: A blood test finds deadly cancers before symptoms start; Research Article: Yuk et al.09:51 Ancient Antarctic rain...
Source: Nature Podcast - Category: Science Authors: Source Type: podcasts
By infecting glioblastoma cells but not healthy brain tissue, some form of the virus could serve a therapeutic purpose.
Source: The Scientist - Category: Science Tags: The Literature Source Type: news
(Institute of Cancer Research) Brain cancer in infants is biologically distinct from other childhood brain tumors and could be successfully treated with targeted drugs, a new study has shown. In the largest and most comprehensive study of infant gliomas to date, scientists found that these tumors are molecularly different from those in older children, helping explain why they tend to be less aggressive.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) The causes of 40 percent of all cases of certain medulloblastoma - dangerous brain tumors affecting children - are hereditary. These are the findings of a recent genetic analysis carried out by scientists from the Hopp Children's Cancer Center (KiTZ), the European Molecular Biology Laboratory (EMBL) and numerous colleagues around the world, which have just been published in the scientific journal Nature.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
(St. Jude Children's Research Hospital) Collaboration co-led by researchers at St. Jude Children's Research Hospital discovers a novel predisposition gene in pediatric medulloblastoma.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
(European Molecular Biology Laboratory) The causes of 40% of all cases of certain medulloblastomas -- dangerous brain tumors affecting children -- are hereditary. These are the findings of a recent genetic analysis carried out by scientists from the European Molecular Biology Laboratory (EMBL) and numerous colleagues around the world. A genetic defect that occurs in 15% of these children plays a key role by destabilizing the production of proteins. The researchers suspect that protein metabolism defects could be a previously underestimated cause of other types of cancer.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
AbstractIntroductionStereotactic radiosurgery (SRS) is an emerging treatment for patients with multiple brain metastases (BM). The present work compares the SRS of multiple brain metastases with whole-brain radiotherapy (WBRT).MethodsWe performed a matched-pair analysis for 128 patients with multiple BM treated with either SRS or WBRT over a 5-year period. Patients were matched pairwise for seven potential prognostic factors. A mixed Cox Proportional Hazards model with univariate and multivariate analysis was fitted for overall survival (OS).  Distant intracranial progression-free survival (icPFS) and local control we...
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
Conclusion Review of literature and our case strengthens the idea of meningioma as a favorable premetastatic niche. Considering that the patient lived with a stable disease for many years, a sudden progress of tumor size in association with neurological deterioration was highly suspected for malign involvement, including the possibility of tumor-to-tumor metastasis. Physicians should be aware about this phenomenon and treat patients accordingly to the underlying disease. [...] Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents  |  Abstract  |&...
Source: Journal of Neurological Surgery Reports - Category: Neurosurgery Authors: Tags: Case Report Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Databases & Libraries | Mitochondria | Neurology